Sentynl Therapeutics Receives FDA Approval for Revolutionary Treatment of Menkes Disease with ZYCUBO® Sentynl Therapeutics has made headlines with the FDA's approval of ZYCUBO®, the first-ever therapy for treating Menkes disease in pediatric patients, promising hope.

Sentynl Therapeutics Receives FDA Approval for Revolutionary Treatment of Menkes Disease with ZYCUBO® #United_States #Solana_Beach #Menkes_Disease #Sentynl_Therapeutics #ZYCUBO